Literature DB >> 12165336

Antiviral and cytotoxic activities of some Indonesian plants.

F Lohézic-Le Dévéhat1, A Bakhtiar, C Bézivin, M Amoros, J Boustie.   

Abstract

Ten methanolic extracts from eight Indonesian medicinal plants were phytochemically screened and evaluated for antiviral (HSV-1 and Poliovirus) and cytotoxic activities on murine and human cancer lines (3LL, L1210, K562, U251, DU145, MCF-7). Besides Melastoma malabathricum (Melastomataceae), the Indonesian Loranthaceae species among which Elytranthe tubaeflora, E. maingayi, E. globosa and Scurrula ferruginea exhibited attractive antiviral and cytotoxic activities. Piper aduncum (Piperaceae) was found active on Poliovirus. S. ferruginea was selected for further studies because of its activity on the U251 glioblastoma cells.

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12165336     DOI： 10.1016/s0367-326x(02)00125-9

Source DB:  PubMed          Journal:  Fitoterapia        ISSN： 0367-326X            Impact factor:   2.882


  14 in total

1.  Acute and subacute dermal toxicity of ethanolic extract of Melastoma malabathricum leaves in Sprague-Dawley rats.

Authors:  Farhan Hanif Reduan; Rosly Mohd Shaari; Nurul Syahirah Ahmad Sayuti; Noordin Mohamed Mustapha; Md Zuki Abu Bakar; Shanmugavelu Sithambaram; Hazilawati Hamzah
Journal:  Toxicol Res       Date:  2020-03-26

2.  Review of Whole Plant Extracts With Activity Against Herpes Simplex Viruses In Vitro and In Vivo.

Authors:  Anna Garber; Lianna Barnard; Chris Pickrell
Journal:  J Evid Based Integr Med       Date:  2021 Jan-Dec

3.  Antiviral Activity of Cananga odorata Against Hepatitis B Virus.

Authors:  Puguh Indrasetiawan; Chie Aoki-Utsubo; Muhammad Hanafi; Sri Hartati; Tutik Sri Wahyuni; Masanori Kameoka; Yoshihiko Yano; Hak Hotta; Yoshitake Hayashi
Journal:  Kobe J Med Sci       Date:  2019-11-12

4.  Diuretic and natriuretic activity of two mistletoe species in rats.

Authors:  Namita Jadhav; C R Patil; K B Chaudhari; J P Wagh; S J Surana; R B Jadhav
Journal:  Pharmacognosy Res       Date:  2010-01

5.  Melastoma malabathricum (L.) Smith Ethnomedicinal Uses, Chemical Constituents, and Pharmacological Properties: A Review.

Authors:  S Mohd Joffry; N J Yob; M S Rofiee; M M R Meor Mohd Affandi; Z Suhaili; F Othman; A Md Akim; M N M Desa; Z A Zakaria
Journal:  Evid Based Complement Alternat Med       Date:  2011-12-28       Impact factor: 2.629

Review 6.  Loranthus ferrugineus: a Mistletoe from Traditional Uses to Laboratory Bench.

Authors:  Omar Z Ameer; Ibrahim M Salman; Ko Jin Quek; Mohd Z Asmawi
Journal:  J Pharmacopuncture       Date:  2015-03

7.  Antioxidant Activity and ROS-Dependent Apoptotic Effect of Scurrula ferruginea (Jack) Danser Methanol Extract in Human Breast Cancer Cell MDA-MB-231.

Authors:  Mohsen Marvibaigi; Neda Amini; Eko Supriyanto; Fadzilah Adibah Abdul Majid; Saravana Kumar Jaganathan; Shajarahtunnur Jamil; Javad Hamzehalipour Almaki; Rozita Nasiri
Journal:  PLoS One       Date:  2016-07-13       Impact factor: 3.240

8.  Pro-apoptotic and cytotoxic effects of enriched fraction of Elytranthe parasitica (L.) Danser against HepG2 Hepatocellular carcinoma.

Authors:  Nimmy Kumar; Subhankar Biswas; Asha Elizabeth Mathew; Subin Varghese; Jessy Elizabeth Mathew; K Nandakumar; Jesil Mathew Aranjani; Richard Lobo
Journal:  BMC Complement Altern Med       Date:  2016-10-26       Impact factor: 3.659

9.  Melastoma malabathricum Ethyl Acetate Fraction Induces Secondary Necrosis in Human Breast and Lung Cancer Cell Lines.

Authors:  Adi Idris; Ihsan N Zulkipli; Nurul Ramizah Zulhilmi; Huan F Lee; Rajan Rajabalaya; Lim Y Chee; Mohamed Majid; Sheba R David
Journal:  Pharmacogn Mag       Date:  2017-10-11       Impact factor: 1.085

10.  Effects of Flower and Fruit Extracts of Melastoma malabathricum Linn. on Growth of Pathogenic Bacteria: Listeria monocytogenes, Staphylococcus aureus, Escherichia coli, and Salmonella typhimurium.

Authors:  Siti Nurhadis Che Omar; Janna Ong Abdullah; Khairul Anuar Khairoji; Sieo Chin Chin; Muhajir Hamid
Journal:  Evid Based Complement Alternat Med       Date:  2013-04-10       Impact factor: 2.629
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.